Sequential treatments with TRK inhibitors in a patient with NTRK fusion-positive sarcoma: A case report.
Yuta KubotaMasanori KawanoTatsuya IwasakiIchiro ItonagaHiroshi TsumuraNobuhiro KakuKazuhiro TanakaPublished in: Medicine (2024)
In the treatment of NTRK fusion-positive tumors, there are cases in which 2 approved first-generation TRK inhibitors can be used sequentially.
Keyphrases